701 VETERANS CIRCLE, WARMINSTER, PA
Financial Results, Press Release
News
Offers Admissible Expert Opinions to Support Its Enablement Defense
Claim Violated Patent Law During Operation Warp Speed
European Patent Revocation for Arbutus Biopharma Corporation's EP 254 Patent
LNP Litigation
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload